Forest Laboratories Inc. has made a series of appointments to its executive leadership team as part of its effort to "flatten and broaden" its organization under a recently announced corporate streamlining plan.
STS Health has rolled out FluNada, a homeopathic throat and nasal spray for relief of cold and flu-like symptoms, to more than 5,000 retail pharmacies. The company said Monday that the over-the-counter cold/flu remedy, launched in January and previously sold through Amazon.
Hundreds of people joined executives from Markwins International and Walgreen Co. and singer Fergie to celebrate the companies’ presentation of $50,000 to fund AIDS research.
The Cardinal Health Foundation has awarded over $350,000 in grants to 29 nonprofit organizations that fight prescription drug abuse.
Chobani Inc. has named former Procter & Gamble Co. executive Dipak Golechha as its chief financial officer.
Coty Inc. has named Patrice de Talhouet as its new chief financial officer, starting early next year. The beauty care giant said Tuesday that de Talhouet will replace Sergio Pedreiro, who will stay on at Coty through March 2014 to provide a seamless transition.
The Biotechnology Industry Organization (BIO) has hired Patrick Plues as senior director of state government relations.
Forest Laboratories Holdings Ltd., a subsidiary of Forest Laboratories Inc., plans to buy the exclusive U.S. rights for Saphris sublingual tablets, a medication for schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a unit of Merck & Co.
Lannett Co. plans to transfer the listing of its common stock to the New York Stock Exchange (NYSE) from NYSE MKT. The generic pharmaceutical company said Monday that it expects its shares to begin trading on the NYSE as of Dec. 13 under its current ticker symbol, LCI. "This has been a tremendous
Cardinal Health Inc. has renewed its primary distribution agreement with pharmacy benefit manager Prime Therapeutics.
L’Oreal Group is forming a travel retail business unit to address the travel beauty care segment.
Merck has received approval from the Food and Drug Administration for Noxafil (posaconazole) 100-mg delayed-release tablets, an antifungal medication.
Fuse Science Inc. is launching a national television advertising campaign featuring 2013 World Series MVP and Boston Red Sox slugger David Ortiz.
Robitussin has introduced Maximum Strength Cough + Chest Congestion DM, new liquid-filled capsules aimed at controlling cough on the go.
Moberg Pharma is expanding North American retail distribution of its Kerasal Neurocream, a topical analgesic for foot pain, with a bigger presence for the product at the largest U.S. drug chain.
Topical BioMedics Inc. has landed retail distribution for its Topricin Foot Therapy Cream at Walgreens, the nation’s largest drug chain. The company said Friday that Walgreens will carry Topricin Foot Therapy Cream in the diabetes care section of its nearly 9,000 drug stores.
